FEATURED COMPANIES
- Envigo RMS LLC (U.S.)
- ICON plc (Ireland)
- PPD Inc. (U.S.)
- SGS S.A. (Switzerland).
- Syneos Health Inc. (U.S.)
Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology], Laboratory Services, and others), Therapeutic Area, End, and Geography - Global Forecast to 2027
The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report includes key industry drivers, restraints, challenges, and opportunities. The growth in the contract research organizations market is mainly attributed to the rising demand for biopharmaceuticals, an increasing number of clinical trials, and growing government support for biopharmaceutical manufacturing. Moreover, opportunities from emerging markets, increasing demand for biosimilars, and continuous advancements in bioprocessing techniques offer significant opportunities for players operating in the contract research organizations market. However, the recent outbreak of COVID-19 has adversely affected the growth of the CROs market during 2019-2020.
Based on service, the clinical research services segment accounted for the largest share of this market in 2019. The large share of this segment is mainly attributed to an increase in the number of clinical trials globally, growth in outsourcing of clinical trials, especially Phase III and Phase II trials, and growth in collaborations between key players and clinical service providers to reduce failures.
Based on therapeutic area, the oncology segment is estimated to account for the largest share of this market in 2020. The large share of this segment is mainly attributed to an increase in the number of oncology clinical trials globally, growth in government investments for the development of personalized medicines for oncology, and high demand for biosimilars for cancer.
Moreover, based on end user, the pharmaceutical & biotechnology companies segment is estimated to account for the largest share of the global contract research organizations market in 2020. An increase in R&D investments for drug development, growing collaborations of pharmaceutical companies with CROs to conduct clinical trials, and government initiatives to support the growth of pharmaceutical companies are the key factors driving the growth of the contract research organizations market for pharmaceutical & biotechnology companies.
An in-depth geographic analysis of the contract research organization market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America commanded the largest share of the global contract research organizations market in 2019, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa.
The key players operating in the global contract research organizations market are IQVIA Holdings Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Charles River Laboratories International, Inc. (U.S.), Wuxi Apptec Co., Ltd. (China), Medpace Holdings, Inc. (U.S.), PRA Health Sciences, Inc. (U.S.), Syneos Health, Inc. (U.S.), PARAXEL International Corporation (U.S.), Envigo RMS LLC (U.S.), ICON plc (Ireland), PPD, Inc. (U.S.), and SGS S.A. (Switzerland).
The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report includes key industry drivers, restraints, challenges, and opportunities. The growth in the contract research organizations market is mainly attributed to the rising demand for biopharmaceuticals, an increasing number of clinical trials, and growing government support for biopharmaceutical manufacturing. Moreover, opportunities from emerging markets, increasing demand for biosimilars, and continuous advancements in bioprocessing techniques offer significant opportunities for players operating in the contract research organizations market. However, the recent outbreak of COVID-19 has adversely affected the growth of the CROs market during 2019-2020.
Based on service, the clinical research services segment accounted for the largest share of this market in 2019. The large share of this segment is mainly attributed to an increase in the number of clinical trials globally, growth in outsourcing of clinical trials, especially Phase III and Phase II trials, and growth in collaborations between key players and clinical service providers to reduce failures.
Based on therapeutic area, the oncology segment is estimated to account for the largest share of this market in 2020. The large share of this segment is mainly attributed to an increase in the number of oncology clinical trials globally, growth in government investments for the development of personalized medicines for oncology, and high demand for biosimilars for cancer.
Moreover, based on end user, the pharmaceutical & biotechnology companies segment is estimated to account for the largest share of the global contract research organizations market in 2020. An increase in R&D investments for drug development, growing collaborations of pharmaceutical companies with CROs to conduct clinical trials, and government initiatives to support the growth of pharmaceutical companies are the key factors driving the growth of the contract research organizations market for pharmaceutical & biotechnology companies.
An in-depth geographic analysis of the contract research organization market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America commanded the largest share of the global contract research organizations market in 2019, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa.
The key players operating in the global contract research organizations market are IQVIA Holdings Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Charles River Laboratories International, Inc. (U.S.), Wuxi Apptec Co., Ltd. (China), Medpace Holdings, Inc. (U.S.), PRA Health Sciences, Inc. (U.S.), Syneos Health, Inc. (U.S.), PARAXEL International Corporation (U.S.), Envigo RMS LLC (U.S.), ICON plc (Ireland), PPD, Inc. (U.S.), and SGS S.A. (Switzerland).
Scope of the report
Global Contract Research Organizations Market, by Service
- Clinical Research Services
- Phase I
- Phase II
- Phase III
- Phase IV
- Early Phase Development Services
- Pre-Clinical Services
- Toxicology Testing
- Pharmacokinetics
- Other Services
- Chemistry, Manufacturing, and Control Services
- Drug Discovery Services
- Laboratory Services
- Bioanalytical Testing
- Analytical Testing
- Batch-Release Testing
- Physical Characterization
- Raw Material Testing
- Stability Testing
- Others
- Consulting Services
Global Contract Research Organizations Market, by Application
- Oncology
- Infectious Diseases
- CNS Disorders
- Cardiology
- Metabolic Disorders
- Immunology
- Others
Global Contract Research Organization Market, by End User
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Medical Device Companies
Global Contract Research Organizations Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Envigo RMS LLC (U.S.)
- ICON plc (Ireland)
- PPD Inc. (U.S.)
- SGS S.A. (Switzerland).
- Syneos Health Inc. (U.S.)
1. Introduction
2. Research Methodology
4. Market Insights
5. Contract Research Organizations Market, By Service
6. Contract Research Organizations Market, By Therapeutic Area
7. Contract Research Organizations Market, By End User
8. Contract Research Organizations Market, By Geography
9. Competitive Landscape
10. Company Profile (Business Overview, Financial Overview, Solutions/Services Portfolio, Strategic Developments )
11. Appendix
List of Tables
List of Figures
Note: Product cover images may vary from those shown
- IQVIA Holdings Inc. (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- Charles River Laboratories International Inc. (U.S.)
- Wuxi Apptec Co. Ltd. (China)
- Medpace Holdings Inc. (U.S.)
- PRA Health Sciences Inc. (U.S.)
- Syneos Health Inc. (U.S.)
- PARAXEL International Corporation (U.S.)
- Envigo RMS LLC (U.S.)
- ICON plc (Ireland)
- PPD Inc. (U.S.)
- SGS S.A. (Switzerland).
Note: Product cover images may vary from those shown